| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.28 | 1-year : | 1.53 |
| Resists | First : | 1.1 | Second : | 1.3 |
| Pivot price | 1.02  |
|||
| Supports | First : | 0.76 | Second : | 0.64 |
| MAs | MA(5) : | 0.87 |
MA(20) : | 1.01 |
| MA(100) : | 0.88 |
MA(250) : | 1.24 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 6.3 |
D(3) : | 9.9 |
| RSI | RSI(14): 38.6 |
|||
| 52-week | High : | 4.25 | Low : | 0.51 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ STRO ] has closed above bottom band by 7.2%. Bollinger Bands are 112% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.84 - 0.84 | 0.84 - 0.85 |
| Low: | 0.78 - 0.79 | 0.79 - 0.79 |
| Close: | 0.79 - 0.81 | 0.81 - 0.82 |
Tue, 11 Nov 2025
Can a trend reversal in STRO lead to recovery - 2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Tue, 11 Nov 2025
Can STRO rally from current levels - 2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Mon, 10 Nov 2025
Will STRO stock see insider buying - July 2025 Big Picture & High Return Stock Watch Alerts - newser.com
Fri, 07 Nov 2025
Piper Sandler Maintains Sutro Biopharma(STRO.US) With Buy Rating, Maintains Target Price $2 - 富途牛牛
Thu, 06 Nov 2025
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Thu, 06 Nov 2025
Sutro Biopharma Announces FDA Clearance for IND Application of STRO-004 and Upcoming Virtual R&D Day - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 85 (M) |
| Shares Float | 60 (M) |
| Held by Insiders | 4.7 (%) |
| Held by Institutions | 69.6 (%) |
| Shares Short | 2,510 (K) |
| Shares Short P.Month | 2,520 (K) |
| EPS | -2.51 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.38 |
| Profit Margin | -199.8 % |
| Operating Margin | 23.6 % |
| Return on Assets (ttm) | -27.6 % |
| Return on Equity (ttm) | -347.7 % |
| Qtrly Rev. Growth | 148 % |
| Gross Profit (p.s.) | 1.42 |
| Sales Per Share | 1.23 |
| EBITDA (p.s.) | -1.87 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -249 (M) |
| Levered Free Cash Flow | -164 (M) |
| PE Ratio | -0.33 |
| PEG Ratio | 0 |
| Price to Book value | -2.15 |
| Price to Sales | 0.66 |
| Price to Cash Flow | -0.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|